We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for health professionals on diagnoses, prevention and treatment of meningococcal disease.
Documents relating to the new meningococcal ACWY (MenACWY) vaccination programme.
The epidemiology, symptoms, diagnosis and management of monkeypox virus infections.
From 1 July 2016, the number of doses of the Meningococcal C (MenC) vaccine in the infant schedule are being reduced.
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The MHRA has conducted a thorough assessment of technical and biological safety information provided by NSO and is satisfied that the modified MAGEC X system can now be used in the UK.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
A guide to the MenACWY vaccine – to protect teenagers and young people from meningitis and septicaemia
How an innovative funding mechanism is saving lives by speeding up the availability of vaccines and making them affordable.
The UK suspension of the MAGEC system (modified MAGEC X system only) has been lifted as of 23 February 2024
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
Travel and clinical advice on Cyclospora including characteristics, symptoms, diagnosis and epidemiology.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
Guidance for veterinary medicines manufacturers and wholesale dealers in GB on selling and supplying products placed on the EU and UK markets before 1 January 2021 and the evidence you may need to provide.
How to apply for an authorisation to manufacture authorised veterinary medicines or medicines marketed under the Exemptions for small pet animals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).